المؤلفون: Dubcenco, E, Beers‐Block, PM, Kim, LP, Schotland, P, Levine, JG, McCloskey, CA, Bashaw, ED

المصدر: CTS: Clinical & Translational Science; Sep2017, Vol. 10 Issue 5, p387-394, 8p

مصطلحات موضوعية: PROTON pump inhibitors, THERAPEUTIC equivalency in drugs, MEDICATION safety, DRUG formularies

الشركة/الكيان: UNITED States. Food & Drug Administration

المؤلفون: Dubcenco E; Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada.; Rutgers, State University of New Jersey, The Biopharma Educational Initiative, Newark, New Jersey, USA.; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Beers-Block PM; Rutgers, State University of New Jersey, The Biopharma Educational Initiative, Newark, New Jersey, USA., Kim LP; Rutgers, State University of New Jersey, The Biopharma Educational Initiative, Newark, New Jersey, USA., Schotland P; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Levine JG; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., McCloskey CA; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Bashaw ED; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

المصدر: Clinical and translational science [Clin Transl Sci] 2017 Sep; Vol. 10 (5), pp. 387-394. Date of Electronic Publication: 2017 Jun 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

مواضيع طبية MeSH: Proton Pump Inhibitors/*adverse effects , Proton Pump Inhibitors/*pharmacokinetics, Adverse Drug Reaction Reporting Systems ; Drug Approval ; Fractures, Bone/chemically induced ; Humans ; Publications ; Therapeutic Equivalency ; Time Factors